medigraphic.com
ISSN 0035-0052 (Print)

2025, Number 4

<< Back Next >>

Rev Mex Pediatr 2025; 92 (4)

Postoperative evolution of newborns with jejunal-ileal intestinal atresia

García H, López-Quiróz F, Oliver-García EF

Language: Spanish
References: 21
Page: 145-150
PDF size: 346.00 Kb.


ABSTRACT

Introduction: jejunoileal atresia is a congenital malformation in which there is a loss of continuity of the intestinal lumen, causing intestinal obstruction. Its management is surgical. Objective: to describe the post-surgical evolution of newborns with jejunoileal intestinal atresia. Material and methods: an observational, descriptive, and retrospective study was conducted. The following variables were recorded: gestational age, birth weight, sex, type of atresia, surgery performed, mortality, and postoperative complications. Results: twenty newborns were included; 60% were male, and 70% were full-term infants. The most frequent types of atresia were type I and IIIa (30% each), mostly located in the ileum. Intestinal resection with enterostomy was performed in 60% of cases. The most frequent surgical comorbidity was a high-output stoma (15%), and the most frequent medical comorbidity was sepsis (40%). Mortality was 5%. Conclusions: newborns with jejunoileal atresia who underwent surgical correction had a low mortality rate, but more than half experienced complications.


REFERENCES

  1. Frischer JS, Azizkhan RG. Jejunoileal atresia and stenosis. In: Coran AG, Caldamone A, Adzick NS, Krummel TM, Laberge JM, Shamberger RC, editors. Pediatric surgery. 7th ed. Philadelphia: Elsevier Saunders; 2012. pp. 1059-1071.

  2. Osuchukwu OO, Rentea RM. Ileal atresia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK557400/

  3. Rokkum H, Johannessen H, Bjornland K. Perioperative and long-term outcome in patients treated for jejunoileal atresia. J Pediatr Gastroenterol Nutr. 2023; 76(4): 434-439.

  4. Bethell GS, Hughes B, Varik RS, Chong C, Hall NJ, Muntean A et al. Management and outcomes of jejunoileal atresia within the United Kingdom. J Pediatr Surg. 2025; 60(7): 162334.

  5. Jarkman C, Salo M. Predictive factors for postoperative outcome in children with jejunoileal atresia. Surg J (NY). 2019; 5(4): e131-e136.

  6. Kumaran N, Shankar KR, Lloyd DA, Losty PD. Trends in the management and outcome of jejuno-ileal atresia. Eur J Pediatr Surg. 2002; 12(3): 163-167.

  7. Bracho E, Davila R, Zalles C, Fernandez E. Prognostic factors related to mortality in newborns with jejunoileal atresia. Cir Cir. 2012; 80: 345-351. Bracho-Blanchet E, González-Chávez A, Dávila-Pérez R, Zalles Vidal C, Fernández-Portilla E, Nieto-Zermeño J. Factores pronóstico para mortalidad en neonatos con atresia intestinal yeyuno-ileal [Prognostic factors related to mortality in newborns with jejunoileal atresia]. Cir Cir. 2012; 80(4): 345-351.

  8. Global PaedSurg Research Collaboration. Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study. Lancet. 2021; 398(10297): 325-339.

  9. Schmedding A, Hutter M, Gfroerer S, Rolle U. Jejunoileal atresia: a national cohort study. Front Pediatr. 2021; 9: 665022.

  10. Calisti A, Olivieri C, Coletta R, Briganti V, Oriolo L, Giannino G. Jejunoileal atresia: factors affecting the outcome and long-term sequelae. J Clin Neonatol. 2012; 1(1): 38-41.

  11. Eeftinck-Schattenkerk LD, Backes M, de Jonge WJ, van Heurn ELW, Derikx JPM. Treatment of jejunoileal atresia by primary anastomosis or enterostomy: Double the operations, double the risk of complications. J Pediatr Surg. 2022; 57(9): 49-54.

  12. García H, Franco-Gutiérrez M, Rodríguez-Mejía EJ, González-Lara CD. Comorbilidad y letalidad en el primer año de vida en niños con atresia yeyunoileal. Rev Invest Clin. 2006; 58(5): 450-457.

  13. Stollman TH, de Blaauw I, Wijnen MH, van der Staak FH, Rieu PN, Draaisma JM et al. Decreased mortality but increased morbidity in neonates with jejunoileal atresia; a study of 114 cases over a 34-year period. J Pediatr Surg. 2009; 44(1): 217-221.

  14. Premkumar MH, Soraisham A, Bagga N, Massieu LA, Maheshwari A. Nutritional management of short bowel syndrome. Clin Perinatol. 2022; 49(2): 557-572.

  15. Ng DHC, Klassen JR, Embleton ND, McGuire W. Protein hydrolysate versus standard formula for preterm infants. Cochrane Database Syst Rev. 2019; 7(7): CD012412.

  16. Lonnerdal B. Bioactive proteins in human milk: health, nutrition, and implications for infant formulas. J Pediatr. 2016; 173 Suppl: S4-S9.

  17. Lyons KE, Ryan CA, Dempsey EM, Ross RP, Stanton C. Breast milk, a source of beneficial microbes and associated benefits for infant health. Nutrients. 2020; 12(4): 1039.

  18. Ottria R, Porta MD, Xynomilakis O, Casati S, Cazzola R, Ciuffreda P. Lipids and lipid signaling molecules in human milk and infant formula, a chemical characterization of relevant biochemical components. J Nutr Biochem. 2024; 126: 109580.

  19. Prachuapthunyachart S, Merani S, Cloonan M, Langnas AN, Quiros-Tejeira RE, Vo HD. Immune function and infectious complications in children with jejunoileal atresia. J Pediatr Surg. 2021; 56(3): 454-458.

  20. Aboalazayem A, Ragab M, Magdy A, Bahaaeldin K, Shalaby A. Outcome of tapering enteroplasty in managing jejunoileal atresia. J Indian Assoc Pediatr Surg. 2022; 27(6): 666-669.

  21. Ezomike UO, Ekenze SO, Amah CC. Outcomes of surgical management of intestinal atresias. Niger J Clin Pract. 2014; 17(4): 479-483.




2020     |     www.medigraphic.com